Quidelortho Corporation

Why Is QuidelOrtho (QDEL) Down 24.5% Since Last Earnings Report?

QuidelOrtho (QDEL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Source: Zacks Mar 13, 2026

QuidelOrtho (QDEL) Valuation Check After Prolonged Share Price Weakness And Earnings Challenges

QuidelOrtho (QDEL) has drawn attention after a prolonged share price slide, with returns over the past month and past 3 months both negative. This has prompted investors to reassess the diagnostics group. See our latest analysis for QuidelOrtho. The recent slide fits a longer pattern, with a 30 day share price return of negative 38.65% and a 1 year total shareholder return of negative 49.66%, suggesting a shift in momentum as investors reassess growth prospects and risk. If this pullback has...

Source: Simply Wall St. Mar 13, 2026

Rice Hall James Buys QuidelOrtho Stock

QuidelOrtho develops diagnostic technologies for healthcare providers worldwide, spanning labs, clinics, and retail settings.

Source: Motley Fool Mar 9, 2026

3 Unprofitable Stocks That Concern Us

Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure.

Source: StockStory Mar 9, 2026

PacBio, CONMED, Moderna, QuidelOrtho, and Tandem Diabetes Shares Are Falling, What You Need To Know

A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the healthcare industry showing significant job losses.

Source: StockStory Mar 6, 2026

QuidelOrtho Stock Analysis: Revenue Decline and Profitability Concerns

Analysis reveals QuidelOrtho faces significant headwinds with declining revenue, negative cash flow, and falling returns, suggesting its valuation may still be optimistic despite a recent stock price drop.

Source: IndexBox Mar 4, 2026